In alibaba, Asia, Bio, Biotech, biotechnology, China, Chinese venture capital, founders fund, Funding, Fundings & Exits, google ventures, Government, GV, Health, HealthTech, IDG Capital, legend capital, life science, Life Sciences, Matrix Partners China, patents, Policy, qiming, Science, Sequoia Capital China, Startups, TC, TechCrunch - Funding & Exits, Technology News, Tencent, Tencent Holdings, VC, Venture Capital
Posted China is funding the future of American biotech
Silicon Valley is in the midst of a health craze, and it is being driven by “Eastern” medicine. It’s been a record year for US medical investing, but investors in Beijing and [...]